The identification and characterization of oxidized RNAs in Alzheimer's disease

Journal of Neuroscience

Volumn 23, Issue 12, 2003, Pages 4913-4921

  Shan, Xiu ^a   Tashiro, Hirofumi ^a   Lin, Chien Liang Glenn ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

8 oxo 7,8 dihydroguanosine; 8OHG; Alzheimer's disease; Oxidative damage; Protein aggregation; Reactive oxygen species; RNA oxidation

Indexed keywords

RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CELL DAMAGE; CONTROLLED STUDY; CYTOPLASM; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; ISOLATION PROCEDURE; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SPECIES IDENTIFICATION; TISSUE SPECIFICITY;

EID: 0038417076     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-12-04913.2003     Document Type: Article

References (46)

1. Adamec E, Mohan P, Vonsattel JP, Nixon RA (2002) Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta Neuropathol (Berl) 104:92-104.
2. Arendt T, Holzer M, Grossmann A, Zedlick D, Bruckner MK (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 68:5-18.
3. Balcz B, Kirchner L, Cairns N, Fountoulakis M, Lubec G (2001) Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. J Neural Transm Suppl 193-201.
4. Belloir B, Kovari E, Surini-Demiri M, Savioz A (2001) Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 64:61-69.
5. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002a) Proteomic identification of oxidatively modified proteins in alzheimer's disease brain, I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562-571.
6. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002b) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain, II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82:1524-1532.
7. Chan SL, Mattson MP (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 58:167-190.
8. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P (1992) Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89:3010-3014.
9. Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Vinals F, Ribalta T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 11:144-158.
10. Fiala ES, Conaway CC, Mathis JE (1989) Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res 49:5518-5522.
11. Fisher N, Meunier B (2001) Effects of mutations in mitochondrial cytochrome b in yeast and man. Deficiency, compensation and disease. Eur J Biochem 268:1155-1162.
12. Focht SJ, Snyder BS, Beard JL, Van Gelder W, Williams LR, Connor JR (1997) Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience 79:255-261.
13. Furlong CE (2000) PON1 status and neurologic symptom complexes in Gulf War veterans. Genome Res 10:153-155.
14. Gabbita SP, Lovell MA, Markesbery WR (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 71:2034-2040.
15. Gartner U, Holzer M, Arendt T (1999) Elevated expression ofp21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 91:1-5.
16. Goda Y (2002) Cadherins communicate structural plasticity of presynaptic and postsynaptic terminals. Neuron 35:1-3.
17. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023.
18. Huntley GW, Gil O, Bozdagi O (2002) The cadherin family of cell adhesion molecules: multiple roles in synaptic plasticity. Neuroscientist 8:221-233.
19. Inohara N, Koseki T, Chen S, Wu X, Nunez G (1998) CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J 17:2526-2533.
20. Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, Senoo-Matsuda N, Yanase S, Ayusawa D, Suzuki K (1998) A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and aging in nematodes. Nature 394:694-697.
21. Iwatsuji K, Nakamura S, Kameyama M (1989) Lymphocyte glutamate dehydrogenase activity in normal aging and neurological diseases. Gerontology 35:218-224.
22. Kasai H, Chung MH, Jones DS, Inoue H, Ishikawa H, Kamiya H, Ohtsuka E, Nishimura S (1991) 8-Hydroxyguanine, a DNA adduct formed by oxygen radicals: its implication on oxygen radical-involved mutagenesis/carcinogenesis. J Toxicol Sci 16 Suppl 1:95-105.
23. Kato A, Ozawa F, Saitoh Y, Hirai K, Inokuchi K (1997) vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett 412:183-189.
24. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 65:710-724.
25. Lovell MA, Markesbery WR (2001) Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol 58:392-396.
26. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34:609-616.
27. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36:747-751.
28. Mecocci P, Beal MF, Cecchetti R, Polidori MC, Cherubini A, Chionne F, Avellini L, Romano G, Senin U (1997) Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol Chem Neuropathol 31:53-64.
29. Mills J, Laurent Charest D, Lam F, Beyreuther K, Ida N, Pelech SL, Reiner PB (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-ctivated protein kinase signal transduction pathway. J Neurosci 17:9415-9422.
30. Moore D, Iritani S, Chambers J, Emson P (2000) Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease. NeuroReport 11:3799-3803.
31. Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y (1997) Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum Genet 101:126-129.
32. Nixon RA (2000) A "protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann NY Acad Sci 924:117-131.
33. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19:1959-1964.
34. Ohta S, Mineta T, Kimoto M, Tabuchi K (1997) Differential display cloning of a novel rat cDNA (RNB6) that shows high expression in the neonatal brain revealed a member of Ena/VASP family. Biochem Biophys Res Commun 237:307-312.
35. Omar RA (1999) Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J Alzheimers Dis 1:139-145.
36. Paragh G, Balla P, Katona E, Seres I, Egerhazi A, Degrell I (2002) Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry, Clin Neurosci 252:63-67.
37. Sadot E, Jaaro H, Seger R, Ginzburg I (1998) Ras-signaling pathways: positive and negative regulation oftau expression in PC12 cells. J Neurochem 70:428-431.
38. Sayre LM, Zelasko DA, Harris PL, Perry, G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097.
39. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88:10540-10543.
40. Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55:342-345.
41. Tanaka M (2002) Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease. J Neurol 249 Suppl 2:II11-II18.
42. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart E (1998) Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 71:1643-1650.
43. Tran PB, Miller RJ (1999) Aggregates in neurodegenerative disease: crowds and power? Trends Neurosci 22:194-197.
44. van Rensburg SJ, Potocnik FC, De Villiers JN, Kotze MJ, Taljaard JJ (2000) Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles. Ann NY Acad Sci 903:200-203.
45. von Eitzen U, Kosel S, Grasbon-Frodl EM, Egensperger R, Graeber MB (2000) Sequence analysis of the MTCYB gene in Parkinson disease. Neurogenetics 3:47-48.
46. Wamer WG, Yin JJ, Wei RR (1997) Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 23:851-858.